Middleby Q1 sales fall 2.2% to $906.6 million; diluted EPS rises to $1.69
Middleby reported first-quarter 2025 net sales of $906.6 million, down 2.2% from a year earlier, while GAAP diluted EPS rose to $1.69 from $1.59 and adjusted EBITDA fell to $182.1 million from $185.8 million. The board also raised the share repurchase authorization by 7.5 million shares, leaving 11.4 million shares available, which the company says equals 21% of its outstanding equity, and it is targeting most free cash flow for buybacks.
Key points
- Net sales were $906.6 million, down 2.2% from $926.9 million; organic net sales fell 3.8%.
- Net earnings rose to $92.4 million from $86.6 million; diluted EPS was $1.69 versus $1.59.
- Adjusted EBITDA was $182.1 million versus $185.8 million a year earlier.
- On May 5, 2025, the board added 7.5 million shares to the buyback, bringing shares available to 11.4 million; about $50 million was repurchased year to date.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:58 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.